Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse
This study has been completed.
Study NCT00699010   Information provided by Acura Pharmaceuticals Inc.
First Received: June 13, 2008   Last Updated: October 22, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Opioid Abuse
Additional conditions recognized in this trial
Substance-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Interventions listed in this trial
Niacin
Oxycodone HCL plus Niacin
Placebo
Oxycodone HCl
Additional drug interventions recognized in this trial
Niacinamide
Nicotinic Acids
Oxycodone
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Antilipemic Agents
Antimetabolites
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Vasodilator Agents
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Acura Pharmaceuticals Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services